1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Renal Dialysis Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Renal Dialysis Equipment Market, United States
3.1 Renal Dialysis Equipment Market, United States, Revenue ($m), 2018-2033
3.1.1 Dialysis Accessories Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Dialysis Machines Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Vascular Access Devices for Hemodialysis Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Renal Dialysis Equipment Market, United States, Volume (Units), 2018-2033
3.2.1 Dialysis Accessories Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Dialysis Machines Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Vascular Access Devices for Hemodialysis Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Renal Dialysis Equipment Market, United States, Average Price ($) , 2018-2033
3.4 Renal Dialysis Equipment Market, United States, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in United States, Renal Dialysis Equipment Market
4.1 Fresenius Medical Care AG & Co KGaA
4.1.1 Company Overview
4.2 Baxter International Inc
4.2.1 Company Overview
4.3 Nipro Corp
4.3.1 Company Overview
4.4 B. Braun Melsungen AG
4.4.1 Company Overview
4.5 Asahi Kasei Corp
4.5.1 Company Overview
4.6 Outset Medical Inc
4.6.1 Company Overview
4.7 Medtronic Plc
4.7.1 Company Overview
4.8 W. L. Gore & Associates Inc
4.8.1 Company Overview
4.9 Toray Industries Inc
4.9.1 Company Overview
4.10 Becton Dickinson and Co
4.10.1 Company Overview
4.11 Nikkiso Co Ltd
4.11.1 Company Overview
5 Renal Dialysis Equipment Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
6.1.2 Nov 20, 2025: American Kidney Fund Hosts Virtual ‘Dialysis at Home’ Event to Support Kidney Community
6.1.3 Nov 18, 2025: Rockwell Medical Appoints Joe Dawson to Board of Directors
6.1.4 Nov 11, 2025: Rockwell Medical Appoints Rashad Brown As Vice President Of Manufacturing And Supply Chain
6.1.5 Nov 03, 2025: United Therapeutics Corporation Announces First Transplant in Expand Clinical Trial of Ukidney
6.1.6 Oct 20, 2025: CAMC Kidney Transplant Center Performs First Robotic Living Donor Nephrectomy In West Virginia
6.1.7 Oct 17, 2025: Ratner Receives NIH Grant to Enhance Dialysis for Patients
6.1.8 Oct 08, 2025: Calyxo Expands Board of Directors as Patient Treatment with CVAC System Exceeds 20000
6.1.9 Sep 30, 2025: Rockwell Medical Appoints Heather Hunter as COO
6.1.10 Sep 24, 2025: CWSL Alumna Sherry S. Bahrambeygui Elected to UC San Diego Foundation Board
6.1.11 Sep 08, 2025: UC San Diego Foundation Announces New Trustees
6.2 Financial Announcements
6.2.1 Mar 05, 2026: Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
6.2.2 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
6.2.3 Nov 12, 2025: Rockwell Medical Announces Third Quarter 2025 Results
6.2.4 Oct 30, 2025: Nephros Schedules Third Quarter 2025 Financial Results Conference Call
6.2.5 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
6.2.6 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
6.2.7 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
6.2.8 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
6.2.9 May 12, 2025: Rockwell Medical Reports Q1 2025 Results
6.2.10 Apr 14, 2025: Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
6.3 Government and Public Interest
6.3.1 Nov 20, 2025: American Kidney Fund Hosts Virtual ‘Dialysis at Home’ Event to Support Kidney Community
6.3.2 Nov 03, 2025: Biogen to Present Scientific Advances in Rare Kidney Disease at ASN Kidney Week 2025
6.3.3 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
6.3.4 Oct 20, 2025: ProKidney Announces Abstracts for Presentation at ASN Kidney Week 2025
6.3.5 Sep 23, 2025: Seastar Medical Presents Early Save Registry Data of Quelimmune in Pediatric Acute Kidney Injury
6.3.6 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
6.4 Other Significant Developments
6.4.1 Nov 10, 2025: Vexev's VxWave System Achieves Clinical Endpoints in Study on Robotic Ultrasound Scanning for Vascular Access
6.4.2 Oct 31, 2025: NKF Launches Home Dialysis Awareness Campaign to Educate Patients
6.4.3 Oct 20, 2025: CAMC Kidney Transplant Center Performs First Robotic Living Donor Nephrectomy In West Virginia
6.4.4 Oct 17, 2025: Ratner Receives NIH Grant to Enhance Dialysis for Patients
6.4.5 Jul 22, 2025: Somatus Surpasses 500,000 Patients Actively Under Management Across All 50 States and DC
6.5 Product News
6.5.1 Nov 10, 2025: Vexev's VxWave System Achieves Clinical Endpoints in Study on Robotic Ultrasound Scanning for Vascular Access
6.5.2 Nov 07, 2025: Real-World Evidence Studies of XPHOZAH Demonstrate Patient Satisfaction and Reduction in Serum Phosphate
6.5.3 Nov 06, 2025: Venova Medical Enrolls First Subjects in VENOS-3 Study of Velocity Percutaneous AVF System
6.5.4 Nov 06, 2025: ProKidney Presents Full Results from Phase 2 REGEN-007 Trial of Rilparencel
6.5.5 Nov 05, 2025: Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula Arm of the WAVE Trial
6.5.6 Nov 03, 2025: United Therapeutics Corporation Announces First Transplant in Expand Clinical Trial of Ukidney
6.5.7 Nov 03, 2025: Biogen to Present Scientific Advances in Rare Kidney Disease at ASN Kidney Week 2025
6.5.8 Oct 20, 2025: ProKidney Announces Abstracts for Presentation at ASN Kidney Week 2025
6.5.9 Oct 08, 2025: Calyxo Expands Board of Directors as Patient Treatment with CVAC System Exceeds 20000
6.5.10 Sep 30, 2025: Nuwellis Announces 92% Survival Rate in Children with Acute Kidney Injury Following Aquadex Treatment
6.5.11 Sep 09, 2025: Nuwellis’ Vivian Secures $3 Million NIH Grant to Enhance Pediatric Fluid Management
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 GlobalData Consulting
7.3 Contact Us
7.4 Disclaimer